Is combination ATG + PTCy prophylaxis always preferable to using each agent separately in haplo-HCT? Скачать
What is the latest data from REACH-3 for ruxolitinib treated patients with SR-cGvHD after crossover? Скачать
What should supportive care look like for patients with GvHD? What role does physical activity pl... Скачать
Mechanisms of action of ibrutinib, ruxolitinib, and belumosudil, and their role in cGvHD treatment Скачать
How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as g... Скачать
How is failure-free survival impacted by belumosudil in cGvHD which has failed prior therapy? Скачать
Is axatilimab for cGvHD well tolerated and what does the preliminary response data look like? Скачать
How could an understanding of non-classical aGvHD organ involvement improve clinical practice? Скачать
How could an understanding of non-classical aGvHD organ involvement improve clinical practice? Скачать
What do you think are the most promising new drugs in the treatment of steroid-refractory cGvHD? Скачать
Do we see differences after cord blood transplantation between European and Japanese patients? Скачать
Is the microbiota biotherapeutic MaaT013 a safe and effective option for steroid-refractory GI GvHD? Скачать
REACH3 study: Should ruxolitinib become SoC for steroid-dependent or refractory chronic GvHD? Скачать
The ROCKstar study (KD025-213): What patients with chronic GvHD benefit most from belumosudil? Скачать
Can the antigen-specific CD8+ T-cell product Nexi-001 be safely and effectively applied in patients? Скачать
Can the combination of HDAC inhibitor panobinostat plus tacrolimus and sirolimus reduce aGVHD? Скачать
ALPHA study: First-in-human data of ALLO-501 and ALLO-647 in R/R large B-cell or follicular lymphoma Скачать
Novel prophylactic therapies available before and after transplantation to reduce the risk of GvHD Скачать
Is the composition of gut fungal microbiota a predictor of mortality after allo-transplantation? Скачать
What are the current treatment recommendations for acute GvHD and the promotion of the GvL effect? Скачать
Peter Bader | EBMT 2019 | Improving long-term outcomes of patients with steroid refractory aGvHD Скачать
Robert Zeiser | EBMT 2019 | Insights into GvHD pathophysiology and strategies to enhance GVL effects Скачать
Jean El Cheikh | EBMT 2019 | Conditioning regimens in patients undergoing stem cell transplantation Скачать
Zinaida Peric | EBMT 2019 | Retrospective cohort analysis on the impact of IBD after allo-SCT Скачать
Shernan Holtan | ASH 2018 | Human chorionic gonadotropin and epidermal growth factor in acute GvHD Скачать
Kate A Markey | ASH 2018 | Pre-transplant and peri-d100 gastrointestinal dysbiosis in chronic GvHD Скачать
Robert Zeiser | ASH 2018 | Novel therapeutic strategies for the treatment of steroid-refractory GvHD Скачать
Prof. Ernst Holler | EBMT 2018 | Current treatments for first line and refractory acute GvHD? Скачать
Dr. Florent Malard | ASH17 | New protocols & strategies to improve patient care in allo-transplant Скачать
Dr. Steven Pavletic | ASH 2017 | T- and B-cell targeting, cellular therapy and risk stratification Скачать
Prof. Attilio Olivieri | EBMT 2018 | What current therapies are available for refractory cGvHD Скачать
Dr. Malard | EBMT | Traitement de première ligne de rituximab pour la cGvHD après allogreffe de CSM Скачать
Dr. Florent Malard | EBMT 2018 | Rituximab-based first line treatment for cGvHD after allogeneic SCT Скачать
Prof. H. Joachim Deeg | EBMT 2018 | Treatment of steroid-refractory GvHD with alpha-1-antitrypsin Скачать
